flucelvax tetra
seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripa, ljudska - virus gripe, инактивированная, split ili površinski antigen - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra treba primjenjivati u skladu sa službenim preporukama.
dalsy 100 mg/5 ml sirup
viatris bh d.o.o. - ibuprofen - sirup - 100 mg/5 ml - 5 mlsirupa sadrži: 100 mg ibuprofena
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - imunomodulatori za mačke, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunomodulatori za mačke, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
bronchostop sine sirup
kwizda pharma gmbh, effingergasse 21, beč, austrija - suhi ekstrakt timijanove zeleni (7-13:1), ekstrakcijsko otapalo: voda tekući ekstrakt korijena bijelog sljeza (1 : 12-14), ekstrakcijsko otapalo: voda - oralna otopina - 0,12 g + 0,83 g/15 ml - urbroj: 15 ml (16,7 g) oralne otopine sadrži: 0,12 g ekstrakta (kao suhi ekstrakt) iz thymus vulgaris l. i/ili thymus zygis l., herba (timijanova zelen) (7-13 : 1), ekstrakcijsko otapalo : voda i 0,83 g tekućega ekstrakta iz althaea officinalis l., radix (korijen običnog bijeloga sljeza) (1 : 12-14), ekstrakcijsko otapalo : voda.
sinecod 7.5 mg/5 ml sirup
glaxosmithkline d.o.o.sarajevo - butamirat - sirup - 7.5 mg/5 ml - 5 ml sirupa sadrži: 7,5 mg butamiratcitrata
bovela
boehringer ingelheim vetmedica gmbh - modificirane žive goveđa virusni proljev virus tipa 1, sobe-цитопатического roditeljske soja ke-9 i pms-om živi goveđa virusni proljev virus tipa 2, ne цитопатического roditeljske soja new york-93 - imunomodulatori za bika, živa virusna cjepiva - za aktivna imunizacija goveda od 3 mjeseca starosti, a za smanjenje гипертермии i kako bi se smanjili smanjenje broja bijelih krvnih stanica uzrokovana virusne dijareje goveda (bvdv-1 i bvdv-2), i smanjiti izlučivanje virusa i вирусемии uzrokovane bvdv-2. za aktivnu imunizaciju goveda protiv bvdv-1 i bvdv-2, kako bi se spriječilo nastanak uporno zarazenih teladi uzrokovanih transplacentalnom infekcijom.
bronchostop sirup
kwizda pharma gmbh, effingergasse 21, beč, austrija - tekući ekstrakt timijanove zeleni (1 : 2-2,5) ekstrakcijsko otapalo: amonijeva otopina 10 % m/m : glicerol 85 % m/m : etanol 90 % v/v : voda (1 : 20 : 70 : 109) tekući ekstrakt korijena običnog bijelog sljeza (1 : 20), ekstrakcijsko otapalo: voda - oralna otopina - 0,77 g + 0,66 g/5 ml - urbroj: 5 ml (5,7 g) otopine sadrži: 0,77 g tekućeg ekstrakta iz thymus vulgaris l. i/ili thymus zygis l., herba (timijanova zelen) (1 : 2-2,5); ekstrakcijsko otapalo: otopina amonijaka 10 % m/m : glicerol 85 % m/m : etanol 90 % v/v : voda (1 : 20 : 70 : 109) i 0,66 g tekućeg ekstrakta iz althaea officinalis l., radix (korijen običnog bijelog sljeza) (1 : 20); ekstrakcijsko otapalo: voda
dalsy 100 mg/5 ml sirup
mylan d.o.o. - ibuprofen - sirup - 100 mg/5 ml - 5 mlsirupa sadrži: 100 mg ibuprofena
hustagil 480 mg/5 ml sirup
takeda pharmaceuticals bh d.o.o. sarajevo - standardizovani tečni ekstrakt toranj timjana - sirup - 480 mg/5 ml - 6 g (5 ml) sirupa sadrži: 480 mg standardizovanog tečnog ekstrakta herbe timijana (1:22,5) sa min. 0,03 % timola (dab)